DETERMINATION OF TOLERABILITY, SAFETY, AND EFFICACY OF PERAMPANEL, A SELECTIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY IN SUBJECTS WITH REFRACTORY PARTIAL SEIZURES

被引：0
|
作者：
Krauss, G. [1 ]
Biton, V.
Klapper, J. [2 ]
Bar, M.
Rektor, I. [3 ]
Vaiciene-Magistris, N. [4 ]
Liigant, A. [5 ]
Kumar, D.
Squillacote, D.
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
[2] Mile High Res Ctr, Denver, CO USA
[3] Masaryk Univ, CS-60177 Brno, Czech Republic
[4] Kaunas Univ Med, Kaunas, Lithuania
[5] Univ Tartu, Tartu, Estonia
来源：
EPILEPSIA | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Levetiracetam (3,000 mg/Day) as an Adjunctive Therapy in Chinese Patients with Refractory Partial Seizures
    Xiao, Zheng
    Li, Jin-Mei
    Wang, Xue-Feng
    Xiao, Fei
    Xi, Zhi-Qin
    Lv, Yang
    Sun, Hong-Bin
    [J]. EUROPEAN NEUROLOGY, 2009, 61 (04) : 233 - 239
  • [42] The efficacy and safety of adjunctive perampanel for the treatment of refractory focal-onset seizures in patients with epilepsy: A meta-analysis
    Li, Yiming
    Zeng, Ya
    Mu, Jie
    Zhou, Dong
    [J]. EPILEPSIA OPEN, 2022, 7 (02) : 271 - 279
  • [43] Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures
    Vazquez, Blanca
    Yang, Haichen
    Williams, Betsy
    Zhou, Sharon
    Laurenza, Antonio
    [J]. EPILEPSIA, 2015, 56 (07) : e90 - e94
  • [44] The safety and tolerability of retigabine 600-1200mg/day as adjunctive therapy in adults with refractory epilepsy with partial-onset seizures
    Porter, R.
    Hirsch, E.
    Lerche, H.
    Hammond, J.
    Varner, J.
    VanLandingham, K.
    Lotay, N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 49 - 50
  • [45] MULTIPLE-DOSE PHARMACOKINETIC STUDY OF PERAMPANEL, A NONCOMPETITIVE SELECTIVE AMPA RECEPTOR ANTAGONIST IN KOREAN HEALTHY SUBJECTS.
    Choi, H.
    Jung, J.
    Noh, Y-H
    Kim, D-J
    Parvez, M.
    Shin, J-G
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S69 - S69
  • [46] Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety
    Lagae, Lieven
    Villanueva, Vicente
    Meador, Kimford J.
    Bagul, Makarand
    Laurenza, Antonio
    Kumar, Dinesh
    Yang, Haichen
    [J]. EPILEPSIA, 2016, 57 (07) : 1120 - 1129
  • [47] LONG-TERM EFFICACY AND TOLERABILITY OF ZONISAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY
    La Neve, A.
    Pietrafusa, N.
    Pontrelli, G.
    Francavilla, T.
    Durante, V.
    Ladogana, M.
    Lisi, T.
    Boero, G.
    [J]. EPILEPSIA, 2012, 53 : 114 - 114
  • [48] Lacosamide: Efficacy and safety as oral adjunctive therapy in adults with partial-onset seizures
    Halasz, P.
    Kalviainen, R.
    Mazurkiewicz-Beldzinska, M.
    Rosenow, F.
    Sullivan, T.
    Hebert, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 209 - 209
  • [49] Efficacy and safety of rufinamide as adjunctive therapy for inadequately controlled partial seizures in pediatric patients
    Glauser, T
    Arzimanoglou, A
    Litzinger, M
    Frank, LM
    Vigevano, F
    Perdomo, C
    Arroyo, S
    [J]. EPILEPSIA, 2005, 46 : 194 - 195
  • [50] Lacosamide: Efficacy and safety as oral adjunctive therapy in adults with partial-onset seizures
    Chung, S.
    Sperling, M.
    Biton, V
    Krauss, G.
    Doty, P.
    Sullivan, T.
    [J]. EPILEPSIA, 2007, 48 : 57 - 57
12345